Osang Healthcare KRX:036220KOSDAQ
오상헬스케어 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked2since Sep 11
In Q2 2026, Osang Healthcare reported revenue of ₩19.1bn, down 54.5% year on year, and an operating loss of ₩8.1bn. Osang Healthcare (오상헬스케어) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Swung to loss 4 quarters of losses Dividend cut Screener
Osang Healthcare quarterly results consolidated, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩19.1bn | -54.5% | −₩8.1bn margin −42.2% | −₩4.3bn |
| Q1 2026 | ₩22.9bn | -28.8% | −₩4.4bn margin −19.2% | −₩3.6bn |
| Q4 2025 derived | ₩29.0bn | +49.5% | −₩3.2bn margin −11.0% | −₩3.6bn |
| Q3 2025 | ₩25.5bn | +24.8% | −₩4.9bn margin −19.1% | ₩3.0bn |
| Q2 2025 | ₩42.0bn | +110.2% | ₩6.4bn margin 15.2% | −₩237m |
| Q1 2025 | ₩32.1bn | +55.3% | ₩4.1bn margin 12.7% | ₩3.9bn |
| Q4 2024 derived | ₩19.4bn | +32.7% | −₩8.2bn margin −42.2% | −₩1.4bn |
| Q3 2024 | ₩20.4bn | +1.9% | −₩7.1bn margin −35.0% | −₩5.5bn |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Osang Healthcare top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.